Latest Respiratory diseases Stories

Anaphylaxis Answers Save Lives And Regrets

2012-09-28 06:24:19

MCLEAN, Va., Sept. 28, 2012 /PRNewswire-USNewswire/ -- What would you do if faced with a child experiencing a life-threatening allergic reaction? It's a question Allergy & Asthma Network Mothers of Asthmatics' national network of Anaphylaxis Community Experts, or ACE Teams, pose in free training programs for educators, families and policymakers across the country. Knowing the answer could save a life and a lifetime of regret. "Allergies, particularly food allergies, can be...

"Modern Family" Star Julie Bowen Joins Mylan Specialty L.P. to Launch Health Awareness Initiative to Address Growing Rate of Life-Threatening Allergic Reactions

2012-09-26 02:24:13

BASKING RIDGE, N.J., Sept. 26, 2012 /PRNewswire/ -- Emmy-award winning actress Julie Bowen, known for her comedic role in "Modern Family," is for the first time publicly sharing her family's experience with life-threatening allergies to help drive a national conversation on this serious health issue. Bowen is partnering with Mylan Specialty L.P. to launch Get Schooled in Anaphylaxis(TM), a multi-faceted public health initiative that aims to increase awareness of and preparedness...

Geroprotectors as a Novel Therapeutic Strategy for COPD, an Accelerating Aging Disease - Published by Dove Medical Press

2012-09-25 23:04:17

A new way of looking at COPD and the Aging Lung London, United Kingdom (PRWEB) September 25, 2012 International Journal of Chronic Obstructive Pulmonary Disease (IJCOPD), published by Dove Medical Press, will highlight one of its most recently published articles: “Geroprotectors as a novel therapeutic strategy for COPD, an accelerating aging disease.” According to Dr. Richard E Russell, IJCOPD Editor-in-Chief, "This excellent review summarises a new way of looking at COPD and...

Newly-Published Study Compares SURFAXIN® with Animal-Derived Surfactants in Well-Established Model of RDS

2012-09-06 02:32:32

WARRINGTON, Pa., Sept. 6, 2012 /PRNewswire/ -- Discovery Laboratories, Inc. (NASDAQ: DSCO), a specialty biotechnology company dedicated to advancing a new standard in respiratory critical care, today announced the publication of SURFAXIN(® )(lucinactant) preclinical data in Pediatric Research. Using a well-established preterm lamb model of respiratory distress syndrome (RDS), study investigators concluded that early intervention with SURFAXIN may mitigate progression of pulmonary...

VIDA Diagnostics introduces its next generation software as a service platform, Apollo® 1.2

2012-09-03 02:21:53

VIENNA, Sept. 3, 2012 /PRNewswire/ -- VIDA Diagnostics, a leading developer of quantitative imaging analysis software for the diagnosis and treatment planning of major pulmonary disease, announced today the release and commercial availability of Apollo® 1.2, here at the European Respiratory Society (ERS) meeting in Vienna, Austria. Apollo 1.2 showcases improved workflow and dataflow functionality streamlining VIDA's software as a service model, new interactive procedure planning...

Asthma Treatment Could Prevent 80% Of Attacks

New Treatment Could Prevent 80% Of Asthma Attacks

2012-09-01 08:15:06

redOrbit Staff & Wire Reports - Your Universe Online A company affiliated with the University of Southampton has reportedly developed a treatment that can help asthmatics battle the infections that cause 80% of their respiratory attacks. The study, which will be presented before the European Respiratory Society's annual congress in Vienna on Sunday, is said to be the first to offer evidence that boosting the immune system of a person suffering from asthma can actually reduce the...

BREATHE LA's Fourth COPD Conference on November 14, 2012

2012-08-14 14:21:35

Living Well with COPD LOS ANGELES, Aug. 14, 2012 /PRNewswire-USNewswire/ -- On November 14(th) (COPD World Awareness Day), BREATHE LA will host its fourth conference on Chronic Obstructive Pulmonary Disease (COPD) held at the USC Heath Sciences Campus Aresty Auditorium in Los Angeles. Policy experts will address live and online audiences as well as present interactive exhibits. The Conference will feature presentations on new approaches to address the disease, promoting early...

Mesothelioma Victims Center Now Offers The Names Of The Best Mesothelioma Law Firms To Families Who Have Recently Lost A Loved One To Mesothelioma

2012-08-10 23:00:08

The Mesothelioma Victims Center says, "We want nothing but the best for a family dealing with a loss to a rare form of cancer called mesothelioma. Provided it's been less than a few years after a loss to mesothelioma we would still like to give the family the names of the most successful mesothelioma law firms in the nation, along with their specific contacts, with the hope one of these very capable mesothelioma law firms can try to get some significant compensation for the...

COPD Exercise Capacity Improves With Tai Chi

2012-08-09 10:34:38

Tai Chi can be used as an effective form of exercise therapy for people with chronic obstructive pulmonary disease (COPD), according to new findings. The research, which was published online today (XX August 2012) ahead of print in the European Respiratory Journal, suggests that this form of exercise can improve exercise capacity and quality of life in people with COPD and may be as beneficial as pulmonary rehabilitation. It is well known that moderate forms of exercise can help COPD...

OrPro Therapeutics Receives NIH Grant Award to Advance Development of Recombinant Thioredoxin for Treatment of Cystic Fibrosis

2012-07-31 02:28:20

SAN DIEGO, July 31, 2012 /PRNewswire/ -- OrPro Therapeutics, Inc. today announced that the company has been awarded a National Heart, Lung and Blood Institute Small Business Innovation Research (SBIR) grant from the National Institutes of Health (NIH). The grant enables OrPro to advance development of its lead product, ORP-100, for the treatment of cystic fibrosis (CF), an inherited genetic disease that affects approximately 80,000 people worldwide. "This award focuses on an...